Panel Discussion: The Drug Approval Process and Access

Description: A panel discussion on the roles of government regulators, academic researchers, and pharmaceutical manufacturers in the process of drug development, clinical trials, and regulatory approval
Runtime: 01:38:06

Speaker: Janet Woodcock, MD
Speaker title: Director, Center for Drug Evaluation and Research
Speaker organization: United States Food and Drug Administration

Speaker: Maria Isaac, MASc, MD, PhD, MFPM
Speaker title: Senior Scientific Officer
Speaker organization: European Medicines Agency

Speaker: Eric Siemers, MD
Speaker title: Distinguished Medical Fellow
Speaker organization: Eli Lilly and Company

Speaker: Robert Lasser, MD, MBA
Speaker title: Group Medical Director, Neurodegenerative Disorders
Speaker organization: F. Hoffmann-LaRoche

Event: 2015 ADAD Family Conference
Location: Washington, DC, USA
Year: 2015

Search tags: research, regulation, drug treatments, drug approvals, drug access, risk and safety, clinical trials, biomarkers, orphan drugs, preclinical Alzheimer’s, public-private partnership, A4 trial, compassionate allowance, accelerated approval, drug development, combination therapy, data sharing